Cymbalta (duloxetine) is one of the more effective medications for nerve pain, and it’s one of only a few drugs the FDA has specifically approved for this purpose. It works best for diabetic peripheral neuropathy, the burning, tingling, or shooting pain that develops in the feet and hands of people with diabetes. In clinical trials, about 1 in 6 patients who took Cymbalta achieved at least a 50% reduction in pain compared to placebo, based on a Cochrane review of the evidence.
How Cymbalta Reduces Nerve Pain
Cymbalta belongs to a class of drugs called SNRIs, which increase levels of two chemical messengers in your nervous system: serotonin and norepinephrine. While both play roles in mood, the pain relief comes primarily from the norepinephrine side. Your spinal cord has a built-in system for dialing down pain signals before they reach your brain. Norepinephrine is one of the key chemicals powering that system.
When nerve damage occurs, this natural pain-dampening pathway weakens. Cymbalta blocks the reabsorption of norepinephrine in the spinal cord, allowing more of it to remain active. That extra norepinephrine activates receptors on nerve cells that quiet the transmission of pain signals in two ways: it reduces the release of excitatory chemicals from damaged nerve fibers, and it decreases the excitability of the spinal cord cells that relay pain to the brain. In animal studies, this effect builds over several days of consistent dosing, which helps explain why the drug doesn’t work immediately.
What the Clinical Evidence Shows
The strongest evidence supports Cymbalta at 60 mg daily for diabetic peripheral neuropathy. A Cochrane review found that patients taking this dose were 65% more likely to achieve at least 50% pain relief within 12 weeks compared to those on placebo. The number needed to treat was 6, meaning for every 6 people who take it, 1 will get meaningful relief they wouldn’t have gotten from a sugar pill. That’s a modest but real benefit, and it places Cymbalta among the better-performing options for this type of pain.
Beyond diabetic neuropathy, Cymbalta is also FDA-approved for fibromyalgia and chronic musculoskeletal pain (including low back pain and osteoarthritis pain). Doctors sometimes prescribe it off-label for other types of nerve pain, such as chemotherapy-induced neuropathy, though the evidence for those uses is thinner.
How It Compares to Gabapentin
Gabapentin (Neurontin) is probably the most commonly prescribed alternative for nerve pain. A meta-analysis of head-to-head trials in diabetic neuropathy found no statistically significant difference between duloxetine and gabapentin for pain relief. They also performed similarly on sleep quality, overall symptom scores, and patients’ own ratings of improvement.
The side effect profiles differ somewhat. In the compared trials, nausea and vomiting were more common with Cymbalta (13.1% vs. 9.7%), while imbalance was more common with gabapentin. Sleepiness occurred with both. This means the choice between the two often comes down to which side effects you’re more willing to tolerate, whether you’re also dealing with depression or anxiety (where Cymbalta has a clear advantage), and how you respond individually.
How Long It Takes to Work
When used for pain, Cymbalta generally starts producing noticeable relief within about two weeks. Full effects can take 6 to 8 weeks to develop. This gradual onset reflects the way the drug slowly restores norepinephrine activity in your spinal cord’s pain-modulating pathways. If you’ve been taking it for 8 weeks at the recommended dose and haven’t noticed improvement, it’s reasonable to discuss alternatives with your prescriber.
Common Side Effects
Across large clinical trials involving nearly 5,000 patients on duloxetine, the most frequently reported side effects were nausea (18%), dry mouth (10%), constipation (7%), and sleepiness (6%). Nausea is the most common reason people struggle with the drug early on, though it tends to improve after the first week or two. Decreased appetite and insomnia also show up more often than with placebo.
About 12% of patients in clinical trials stopped taking Cymbalta because of side effects. That’s a meaningful dropout rate, but it also means the large majority were able to continue treatment. Starting at a lower dose and increasing gradually can help reduce early nausea and other startup effects.
Stopping Cymbalta Safely
Cymbalta is one of the antidepressants most associated with withdrawal symptoms if stopped abruptly. Because your nervous system adapts to the drug’s presence, suddenly removing it can trigger nausea, headaches, dizziness, irritability, anxiety, and what some people describe as “brain zaps,” brief electrical-sensation feelings in the head.
These symptoms can begin within a day or two of stopping or reducing your dose. They last anywhere from a few days to several weeks, depending on how long you’ve been on the medication and your dose. A gradual taper, slowly reducing the dose over time, is the standard approach to minimize these effects. This is not a drug you should stop on your own without a plan.
Who Benefits Most
Cymbalta tends to be a particularly good fit for people whose nerve pain coexists with depression or anxiety, since it treats both. It’s a first-line option for diabetic neuropathy in most treatment guidelines, alongside gabapentin and pregabalin. For people who haven’t responded to one of those medications alone, some doctors will combine Cymbalta with gabapentin, since they work through different mechanisms.
It’s less likely to be the right choice if you have liver problems, drink heavily, or take other medications that affect serotonin levels. The standard dose for nerve pain is 60 mg once daily, and unlike some pain medications, higher doses haven’t shown additional benefit for neuropathy in clinical trials.